Claudin-5 has been studied in psychiatric disorders such as schizophrenia, bipolar disorder, obsessive–compulsive disorder (OCD), attention-deficit/hyperactivity disorder, and autism spectrum disorder, with inconsistencies across studies (8). This evidence concerns the gene CLDN5 and psychiatric disorder.